COCRYSTAL PHARMA, INC. Deferred Tax Liabilities, Gross
COCRYSTAL PHARMA, INC. (COCP) had Deferred Tax Liabilities, Gross of $313.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-31
- 2025-12-31: Deferred Tax Liabilities, Gross $313.00K.
- 2024-12-31: Deferred Tax Liabilities, Gross $387.00K.
- 2023-12-31: Deferred Tax Liabilities, Gross $439.00K.
- 2022-12-31: Deferred Tax Liabilities, Gross $87.00K.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $313.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $387.00K 10-K · filed 2026-03-31 | |
| 2023-12-31 | $439.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $87.00K 10-K · filed 2024-03-28 | |
| 2021-12-31 | $126.00K 10-K · filed 2023-03-29 | |
| 2020-12-31 | $127.00K 10-K · filed 2022-03-23 | |
| 2019-12-31 | $9.00K 10-K · filed 2021-03-17 | |
| 2013-09-30 | $102.02K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $102.02K 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $102.02K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $102.02K 10-Q · filed 2013-11-18 | |
| 2012-09-30 | $102.02K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $102.02K 10-Q/A · filed 2012-09-28 | |
| 2012-03-31 | $102.02K 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | $102.02K 10-K · filed 2013-04-01 | |
| 2011-09-30 | $98.75K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $69.02K 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | $98.75K 10-K · filed 2012-04-16 | $69.02K 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |